• Store

Critical Care Management of Pediatric HSCT and
Cell Therapy Patients Workshop

February 20, 2019 | The University of Texas MD Anderson Cancer Center Children's Cancer Hospital | Houston, TX

CC Workshop Banner

Join the Association of Pediatric Hematology/Oncology Nurses and the Pediatric Acute Lung Injury and Sepsis Investigators at the University of Texas MD Anderson Cancer Center Children's Cancer Hospital for a one day workshop, Critical Care Management of Pediatric HSCT & Cell Therapy Patients. This workshop was developed to provide:

  • Didactic training regarding the prevention and diagnosis of common complications among children undergoing HSCT and cell therapy which require critical care intervention.
  • Provide inter-disciplinary simulation training regarding management of common complications among children undergoing HSCT and cell therapy which require critical care intervention.
  • Identify knowledge gaps and future collaborative research opportunities
  • Key areas of interest include VOD, GVHD, Infectious Complications and Management of CART Complications, improving inter-service transitions of care.

Space is limited to the first 70 people that register. 

Workshop Planning Committee Co-Chairs

Kris Mahadeo, MD MPH

MD Anderson Children's Cancer Hospital

Dr. Mahadeo is the Section Chief for Pediatric Stem Cell Transplantation and Cellular Therapy at MD Anderson Children’s Cancer Hospital in Houston, Texas where he oversees the pediatric stem cell transplantation program, immune effector cellular therapies and associated clinical trials. Dr. Mahadeo co-chairs the Pediatric Acute Lung Injury and Sepsis Investigators (PALISI)-HSCT Subgroup. He serves as the co-director of this symposia and will co-chair Session III regarding prospective inter-disciplinary collaborations regarding critical care considerations for pediatric HSCT and cell therapy patients. Dr. Mahadeo is an inspector for the Foundation for the Accreditation of Cellular Therapy (FACT) and is an expert in matters relating to cellular therapy regulatory compliance, data assurance and patient safety. His academic interests focus on expanded access of cellular therapies for advanced malignancies and reducing toxicities associated with such therapies.


Jerelyn Moffet, MS RN CPNP

Duke University

Jerelyn Moffet is a pediatric nurse practitioner in pediatric hematopoietic cell transplant. She earned her degrees from the University of Wisconsin. Jerelyn has been practicing in the field of pediatric oncology and stem cell transplant for over 25 years. In addition to her clinical practice, she is involved in research in pediatric oncology, hematopoietic cell transplant and critical care medicine, more specifically outcomes and management of HCT patients requiring intensive care. She is a long-standing member of the PALISI HCT executive committee.


Joan O'Hanlon Curry, MS RN CPNP CPON®

MD Anderson Children's Cancer Hospital

Joan O'Hanlon Curry started her career in pediatric hematology/oncology nursing 25 years ago as a staff nurse at Memorial Sloan Kettering Cancer Center. She received her PNP degree from Columbia University in 1998. She worked at The Children’s Hospital at Montefiore for 13 years as the nurse manager for the inpatient and outpatient pediatric hematology/oncology/bmt program.

In January 2018, she joined The University of Texas MD Anderson Cancer Center as the Administrative Director, Pediatric Clinical services. She is currently serving as President-Elect for APHON.

Workshop Speakers

Joseph R. Angelo, MD

Baylor College of Medicine's Texas Children's Hospital

Dr. Angelo is a Pediatric Nephrologist at Baylor College of Medicine’s Texas Children’s Hospital. He is a content expert in renal complications with Venoocclusive disease and has extensive experience in renal complications following chemotherapy exposure. His academic interests include renal complications for Bone Marrow Transplant recipients and he has been an active PALISI member since 2013. He is also the Pediatric Nephrology Fellowship Training Program Director at Texas Children’s Hospital.


Daryl Anildes-Gumban, MSN RN CCRN CSC

MD Anderson Cancer Center

Daryl started her career in nursing 25 years ago. She moved from Chicago and joined MD Anderson as a clinical nurse in the Perioperative area in 2013. She transitioned as a simulation educator last year. She collaborates with educators and clinicians and function as a simulation consultant on scenario development and implementation of simulation activities.


Christine Duncan, MD

Dana Farber/Boston Children's Hospital

Dr. Christine Duncan completed her fellowship in Pediatric Hematology and Oncology at Boston Children’s where she remains as a senior physician in pediatric blood and marrow transplant and as an Assistant Professor of Pediatrics at Harvard Medical School. She is the past chair of the Pediatric Acute Lung Injury and Sepsis Investigators (PALISI) Network’s Hematopoietic Stem Cell Transplant (HSCT)/Oncology subgroup and currently sits on the executive committee for the subgroup.


Kathleen Faltus, BSN RN

MD Anderson Cancer Center

Kathleen Faltus is a BSN graduate from Salve Regina University in Newport, RI where she resided. Following graduation, she moved to Houston, TX to work at MD Anderson. She has been a nurse in the children’s cancer hospital for 6 years. This past September she co-presented on CAR T Cell implementation and side effects at the APHON conference in Savannah, Georgia.


Sarah Featherston, RN CPN

MD Anderson Cancer Center

Sarah Featherston is a Pediatric Stem Cell Transplant Coordinator. She began her nursing career on the pediatric unit at MD Anderson Cancer Center in 2010. In 2015, she transitioned to the role of Pediatric Stem Cell Nurse Coordinator instrumental in the roll out of CAR T cell therapy as a standard of care at MDACC.


Avis Harden, MD

MD Anderson Cancer Center

Dr. Harden is a 2nd-year pediatric hematology/oncology fellow whose area of interest is transplant and cell therapy.


Jennifer McArthur, DO

St. Jude Children's Research Hospital

Jennifer McArthur completed her fellowship in Pediatric Critical Care Medicine at the University of Tennessee Health Sciences Center and Pediatric Hematology and Oncology at St. Jude Children’s Research Hospital in 2002. The majority of her academic career has been at the Children’s Hospital of Wisconsin where she continues to serve as an Adjunct Associate Professor of Pediatrics. In 2016 she returned to St. Jude Children’s Research Hospital where she is an Associate Member in the Department of Pediatric Medicine. She is the co-founder of the Pediatric Acute Lung Injury and Sepsis Investigators (PALISI) Network’s Hematopoietic Stem Cell Transplant (HSCT)/Oncology subgroup and currently sits on the executive committee for the subgroup.


David McCall, MD

MD Anderson Cancer Center

Dr. David McCall is a 2nd-year pediatric hematology/oncology fellow. His area of interest is solid tumors.


Sana Mohiuddin, MD

MD Anderson Cancer Center

Dr. Sana Mohiuddin is a pediatric hematology/oncology fellow whose area of interest is pediatric bone sarcomas.


Dristhi Ragoonanan, MD

MD Anderson Cancer Center

Dr. Ragoonanan is a first-year pediatric hematology-oncology fellow whose areas of interest are cellular therapy along with palliative care and quality of life.


Shehla Razvi, MD

MD Anderson Cancer Center

Shehla Razvi is Assistant Professor of Critical Care at Children’s Cancer Hospital.  She has interests in oncology critical care along with an academic interest in nutrition for critically ill patients.  She has been faculty at MD Anderson Cancer since 2014, is an active member of PALISI and one of our rare native Texans!


Basirat Shoberu, PharmD, BCPPS

Children's Hospital at Montefiore

Basirat Shoberu is a Board Certified Pediatric Pharmacist from The Children's Hospital at Montefiore in the Bronx, NY. Her areas of interest include Blood and Marrow Transplantation and Quality Improvement.


Andre Stokhuyzen, PNP-AC

Duke University

Andre Stokhuyzen is a pediatric nurse practitioner in the field of Pediatric Blood and Marrow Transplant. He has been in clinical practice for over 18 years. Andre leads various transplant education sessions for nurses, allied health professionals and other disciplines that work with pediatric transplant patients. His area of expertise is infectious diseases, immune reconstitution and immunotherapy creating department guidelines, numerous research projects and their associated publications.


Priti Tewari, MD

MD Anderson Cancer Center

Dr. Tewari is a Pediatric Stem Cell Transplant physician at Children’s Cancer Hospital at MD Anderson Cancer Center with interests in GVHD and Supportive Care for Transplant recipients. She is also the Pediatric Hematology-Oncology Fellowship Program Director for the Division and an active inspector for The Foundation for the Accreditation of Cellular Therapy (FACT).


Jennifer Vittorio, MD

New York-Presbyterian Morgan Stanley Children's Hospital

Dr. Vittorio is an Assistant Professor of Pediatrics in the Division of Gastroenterology and Hepatology at New York-Presbyterian Morgan Stanley Children’s Hospital at Columbia University Medical Center. Prior to her faculty appointment, Dr. Vittorio earned a degree in Neuroscience from Fairfield University. She completed her medical education, internship and residency at Georgetown University Hospital. She then went on to pursue a fellowship in Pediatric Gastroenterology, Hepatology and Nutrition and an Advanced Transplant Hepatology fellowship at Columbia University Medical Center (CUMC).

Having completed a dual residency in both internal medicine and pediatrics, Dr. Vittorio has a particular interest and specializes in the transition of adolescent and young adult liver transplant recipients from pediatric to adult health care services. She is the founder and director of the PLATINUM (Pediatric Liver to Adult Transition) Program at CUMC. This program is focused on the enhancement of self-management behaviors and transition readiness in pediatric liver transplant recipients through a structured, multidisciplinary approach to transition planning.

Her other clinical and research interests include pediatric transplant hepatology, acute liver failure, and cholestatic liver disease in children.

Accreditation and Disclaimers

The Association of Pediatric Hematology/Oncology Nurses (APHON) is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center's Commission on Accreditation.

Participants will be awarded 6 CNE contact hours upon completion of the entire workshop, post-test and evaluation.

CNE certificates will be available to print online at the conclusion of the conference. You should be aware of the continuing education requirements of your state board of nursing, especially for those states in which continuing education is mandatory.

Learning Gap

Description of current state:
Innovative models are needed to increase access to palliative care services and continuity across the spectrum of care, and to support the bedside clinicians providing direct primary palliative care

Description of desired/achievable state:
Nurses will begin to utilize the precepts of palliative care effectively in their primary bedside clinical practice in caring for neonates, children, adolescents, young adults with hematologic and oncologic serious illnesses and their families, from the time of diagnosis through end of life and bereavement

Identified Gap:
The field of palliative medicine is relatively new to healthcare and many clinicians lack understanding of the major concepts & practices, especially in pediatric hematology/oncology. Clinicians lack understanding of how to integrate the tenets of palliative care concurrently with curative intent therapies.

The educational content in this program is designed to help close this identified learning gap by addressing gaps in knowledge and skill.

Learning Outcome

The learner will be able to identify innovative strategies essential for nurses to integrate primary palliative care into the plan of care for children, adolescents, and young adults with hematologic and oncologic serious illness and their families for promotion of comfort and to optimize quality of life.

The measurement of this outcome will be evidenced by pre and post testing as well as the results of 30, 60 and 90 day surveys.

Pharmacology Content

Sessions indicated as having pharmacology content as calculated by the APHON Palliative Care Planning Committee must be submitted to your state’s nursing board. APHON does not award pharmacology credit. APHON recommends that attendees retain a copy of the program guide for supportive documentation. Please note that you may not apply nursing CHs toward pharmacology content; the content may be applied in only one area - nursing contact hours or pharmacology content.

Disclosure

A staff member, volunteer (faculty), or their family member who has an affiliation with a commercial company must declare that relationship in advance of involvement with an education activity that could be used as a forum to promote the interest of that company and its products. The material presented in this activity represents the opinion of the presenters and not necessarily the views of APHON.

There are no disclosures to report for this activity.

ONCC Official Statement and Disclaimer

Individual Learning Needs Assessment (ILNA) Coding

The program content has been reviewed by the Oncology Nursing Certification Corporation (ONCC) and is acceptable for recertification points. Nurses attending the workshop may apply 15 points to any of the following CPHON ILNA categories: symptom management, psychosocial, end-of-life or professional.

ONCC review is only for designating content to be used for recertification points and is not for CNE accreditation. CNE programs must be formally approved for contact hours by an acceptable accreditor/approver of nursing CE to be used for recertification by ONCC. If the CNE provider fails to obtain formal approval to award contact hours by an acceptable accrediting/approval body, no information related to ONCC recertification may be used in relation to the program. 

General Workshop Information

The Critical Care Management of Pediatric HSCT & Cell Therapy Patients Workshop is a nonsmoking event. Infants and children are not allowed in sessions. Mobile devices must be turned on vibrate during educational sessions. Please be courteous to your fellow attendees. The dress is business casual. As in past conferences & workshops, a professional photographer may take photos of attendees at the workshop. These photos are for APHON use only and may appear on APHON's website, in printed brochures, or other promotional materials. Attendee registration grants APHON permission and consent for use of this photography.

To learn more about the event, check out the workshop schedule or plan your trip!